Postgraduate course presentation. Cromolyn sodium in the treatment of asthma: changing concepts.
D000281:Administration, Intranasal; D000402:Airway Obstruction / Q000188:drug therapy; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001986:Bronchial Spasm / Q000188:drug therapy; D002630:Chemotactic Factors / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D006168:Guinea Pigs; D000882:Haplorhini; D006636:Histamine Release; D006801:Humans; D016209:Interleukin-8; D008134:Long-Term Care; D008407:Mast Cells / Q000378:metabolism; D013458:Sulfur Dioxide / Q000494:pharmacology; D013806:Theophylline / Q000627:therapeutic use
D002630:Chemotactic Factors; D016209:Interleukin-8; D013458:Sulfur Dioxide; D013806:Theophylline; D004205:Cromolyn Sodium